Open

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN

Testing Radiation Therapy with or without Cisplatin for Head and Neck Cancer

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina

What will be asked of you

At each visit, you will receive labs, meet with a provider for clinical assessment, see a member of the study team to fill out questionnaires and provide updates on any symptoms or changes. The study also involves imaging at indicated time points and willingness to take medication as instructed.

In-person visits:
8-10

Total length of participation:
36 Months

Looking for Specific Volunteers

Able to participate:

Confirmed diagnosis of SCC of Head/Neck
Underdone surgery of primary tumor with curative intent

Not eligible if:

• Previous irradiation of the Head and neck that could overlap in radiation areas for current disease
Recurrent Disease or multiple primaries
women must not be pregnant and breast feeding

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Lineberger Comprehensive Cancer Center
cancerclincialtrials@med.unc.edu
(919) 966-4432

Visit Study Website

Primary Visit Location

NC Memorial Hospital
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Sid Sheth
Lineberger Comprehensive Cancer Center

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Head and Neck)

IRB Number

25-0508

ClinicalTrials.gov

NCT02734537

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.